US10617662B2ActiveUtilityA1
Autophagy activation-induced compound for improving skin inflammation for aging
Est. expiryJun 24, 2036(~10 yrs left)· nominal 20-yr term from priority
Inventors:Chaejin LimHeung Jae KimHwa-Jee ChungJuyeon JungKayoung ShinBeom Cheol KimSeok-Jeong YoonMyung Ho KorSeon-Deok KwonKeedon Park
A61Q 19/10A61P 17/00A61P 25/14A61K 47/12A61K 47/06A61Q 1/00A61Q 19/00A61K 31/197A23V 2200/318C07C 237/12A61K 8/442A61K 8/44A61P 3/10A61K 31/195A61K 47/26A61K 9/0014A61K 9/48A61K 31/198A61P 17/06A23V 2002/00A61K 2800/74A23L 33/10A61P 25/28A61K 47/32A61K 9/20A61P 25/16
76
PatentIndex Score
1
Cited by
6
References
23
Claims
Abstract
Provided are a novel autophagy activation-inducing compound or salt thereof, and a use thereof, and particularly, a medicinal composition for treatment and prevention of neurodegenerative diseases, type II diabetes, or atopy or psoriasis dermatitis, a cosmetic composition for alleviation of aging or atopy or psoriasis dermatitis, and a food composition, including the compound capable of inducing autophagy activation or a pharmaceutically acceptable salt thereof.
Claims
exact text as granted — not AI-modifiedThe invention claimed is:
1. An autophagy activation-inducing compound represented by the following Chemical Formula 1:
wherein
R is hydrogen or —X—R 1 ; X is a single bond or —CO—; and R 1 is C1-C20 substituted or unsubstituted alkyl,
or pharmaceutically acceptable salt thereof.
2. The autophagy activation-inducing compound or pharmaceutically acceptable salt thereof of claim 1 , wherein it is an autophagy activation-inducing compound represented by the following Chemical Formula 2:
wherein
R′ is hydrogen or —X—R 2 ; X is a single bond or —CO—; and R 2 is C1-C20 substituted or unsubstituted alkyl.
3. The autophagy activation-inducing compound or pharmaceutically acceptable salt thereof of claim 2 , wherein X is —CO—, and R 2 is C1-C20 substituted or unsubstituted alkyl.
4. A medicinal composition for treatment and prevention of atopy or psoriasis skin diseases comprising the autophagy activation-inducing compound or pharmaceutically acceptable salt thereof of claim 1 .
5. A medicinal composition for treatment and prevention of type II diabetes comprising the autophagy activation-inducing compound or pharmaceutically acceptable salt thereof of claim 1 .
6. A medicinal composition for treatment and prevention of neurodegenerative diseases comprising the autophagy activation-inducing compound or pharmaceutically acceptable salt thereof of claim 1 .
7. The medicinal composition of claim 6 , wherein the neurodegenerative diseases are Alzheimer's disease, Huntington's disease, or Parkinson's disease.
8. The medicinal composition of claim 4 , wherein the compound
or pharmaceutically acceptable salt thereof is comprised at 0.0001 to 10 wt. %.
9. The medicinal composition of claim 4 , wherein it is used in a form of tablets, pills, capsules, granules, pulverized forms, powders, liquids, patches, coating agents or injections.
10. A cosmetic composition comprising the autophagy activation-inducing compound or pharmaceutically acceptable salt thereof of claim 1 .
11. The cosmetic composition of claim 10 , wherein the autophagy activation-inducing compound or pharmaceutically acceptable salt thereof is comprised at 0.0001 to 1 wt. %.
12. The cosmetic composition of claim 10 , wherein the composition is at least one selected from the group consisting of a formulation of suspension, emulsion, paste, gel, cream, lotion, powder, soap, surfactant-containing cleansing, oil, powder foundation, emulsion foundation, wax foundation and spray.
13. A food composition comprising the autophagy activation-inducing compound or pharmaceutically acceptable salt thereof of claim 1 .
14. A medicinal composition for treatment and prevention of atopy or psoriasis skin diseases comprising the autophagy activation-inducing compound or pharmaceutically acceptable salt thereof of claim 2 .
15. A medicinal composition for treatment and prevention of atopy or psoriasis skin diseases comprising the autophagy activation-inducing compound or pharmaceutically acceptable salt thereof of claim 3 .
16. A medicinal composition for treatment and prevention of type II diabetes comprising the autophagy activation-inducing compound or pharmaceutically acceptable salt thereof of claim 2 .
17. A medicinal composition for treatment and prevention of type II diabetes comprising the autophagy activation-inducing compound or pharmaceutically acceptable salt thereof of claim 3 .
18. A medicinal composition for treatment and prevention of neurodegenerative diseases comprising the autophagy activation-inducing compound or pharmaceutically acceptable salt thereof of claim 2 .
19. A medicinal composition for treatment and prevention of neurodegenerative diseases comprising the autophagy activation-inducing compound or pharmaceutically acceptable salt thereof of claim 3 .
20. A cosmetic composition comprising the autophagy activation-inducing compound or pharmaceutically acceptable salt thereof of claim 2 .
21. A cosmetic composition comprising the autophagy activation-inducing compound or pharmaceutically acceptable salt thereof of claim 3 .
22. A food composition comprising the autophagy activation-inducing compound or pharmaceutically acceptable salt thereof of claim 2 .
23. A food composition comprising the autophagy activation-inducing compound or pharmaceutically acceptable salt thereof of claim 3 .Cited by (0)
No later patents cite this yet.
References (0)
No backward citations on record.